Company
TREACE MEDICAL CONCEPTS, INC.
TMCI · CIK 0001630627
Purchase of 11,000 shares at $4.3392 per share.
Reporting Person Treace John T. · Officer Title Chief Executive Officer · Transaction Code P
Traded Aug 24, 2026 · Disclosed Aug 24, 2026
Source: SEC Form 4 · 0001193125-26-363737 · filed 2026-08-24 · View filing →
Purchase of 5,000 shares at $4.3495 per share.
Reporting Person Treace John T. · Officer Title Chief Executive Officer · Transaction Code P
Traded Aug 21, 2026 · Disclosed Aug 24, 2026
Source: SEC Form 4 · 0001193125-26-363737 · filed 2026-08-24 · View filing →
Purchase of 39,944 shares at $4.4356 per share.
Reporting Person Treace John T. · Officer Title Chief Executive Officer · Transaction Code P
Traded Aug 20, 2026 · Disclosed Aug 24, 2026
Source: SEC Form 4 · 0001193125-26-363737 · filed 2026-08-24 · View filing →
Disposition (code F) of 16,253 shares at $0 per share.
Reporting Person Elder Scot Michael · Officer Title Chief Legl & Comp Off, CorpSec · Transaction Code F
Traded Aug 9, 2026 · Disclosed Aug 12, 2026FILED +3 DAYS
Source: SEC Form 4 · 0001193125-26-347222 · filed 2026-08-12 · View filing →
Disposition (code F) of 37,102 shares at $0 per share.
Reporting Person Hair Mark · Officer Title Chief Financial Officer · Transaction Code F
Traded Aug 9, 2026 · Disclosed Aug 12, 2026FILED +3 DAYS
Source: SEC Form 4 · 0001193125-26-347223 · filed 2026-08-12 · View filing →
Disposition (code F) of 9,814 shares at $0 per share.
Reporting Person Scanlan Sean F. · Officer Title Chief Innovation Officer · Transaction Code F
Traded Aug 9, 2026 · Disclosed Aug 12, 2026FILED +3 DAYS
Source: SEC Form 4 · 0001193125-26-347275 · filed 2026-08-12 · View filing →